SUSTAINED SUPPRESSION OF THE PITUITARY-GONADAL AXIS BY LEUPRORELIN 3-MONTH DEPOT MICROSPHERES IN RATS AND DOGS

被引:44
作者
OKADA, H
DOKEN, Y
OGAWA, Y
TOGUCHI, H
机构
[1] DDS Research Laboratories, Takeda Chemical Industries, Ltd, Yodogawa, Osaka
关键词
LEUPRORELIN (LEUPROLIDE); 3-MONTH DEPOT MICROSPHERES; SUSTAINED DRUG RELEASE; PHARMACOLOGICAL EFFECTS; SUPPRESSION OF PITUITARY-GONADAL AXIS; RATS AND DOGS;
D O I
10.1023/A:1018905403359
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The pharmacological effects of leuprorelin three-month depot microspheres were investigated in rats and dogs. After s.c. and i.m. injection, the microspheres provided similar linear drug release and sustained serum drug levels for 3 months. Persistent suppression of serum LH, FSH (in rats) and testosterone (in rats and dogs) for over 16 weeks was achieved when the microspheres were given at a dose of 100 (rat) and 25.6 (dog) mu g/kg/day. These hormone release responses upon periodic challenge tests revealed that a single injection of the microspheres caused dramatic suppression of the function of the pituitary-gonadal system for 15 weeks in rats. The growth of the genital organs was also suppressed dose-dependently by injection of the microspheres over 3 months; the strongest suppression was achieved at a dose of 100 mu g/kg/day. This three-month depot formulation is expected to be more convenient than the one-month depot with improved patient compliance and therapeutic effects.
引用
收藏
页码:1199 / 1203
页数:5
相关论文
共 11 条
[1]  
Kent J, 1987, US Patent, Patent No. [4,675,189, 4675189, 4:675:189]
[2]   CONTROLLED RELEASE OF LHRH AGONIST, LEUPROLIDE ACETATE, FROM MICROCAPSULES - SERUM DRUG LEVEL PROFILES AND PHARMACOLOGICAL EFFECTS IN ANIMALS [J].
OGAWA, Y ;
OKADA, H ;
HEYA, T ;
SHIMAMOTO, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1989, 41 (07) :439-444
[3]  
OKADA H, 1988, J PHARMACOL EXP THER, V244, P744
[4]   PREPARATION OF 3-MONTH DEPOT INJECTABLE MICROSPHERES OF LEUPRORELIN ACETATE USING BIODEGRADABLE POLYMERS [J].
OKADA, H ;
DOKEN, Y ;
OGAWA, Y ;
TOGUCHI, H .
PHARMACEUTICAL RESEARCH, 1994, 11 (08) :1143-1147
[5]   PHARMACOKINETICS OF ONCE-A-MONTH INJECTABLE MICROSPHERES OF LEUPROLIDE ACETATE [J].
OKADA, H ;
INOUE, Y ;
HEYA, T ;
UENO, H ;
OGAWA, Y ;
TOGUCHI, H .
PHARMACEUTICAL RESEARCH, 1991, 8 (06) :787-791
[6]   SUSTAINED PHARMACOLOGICAL ACTIVITIES IN RATS FOLLOWING SINGLE AND REPEATED ADMINISTRATION OF ONCE-A-MONTH INJECTABLE MICROSPHERES OF LEUPROLIDE ACETATE [J].
OKADA, H ;
HEYA, T ;
OGAWA, Y ;
TOGUCHI, H ;
SHIMAMOTO, T .
PHARMACEUTICAL RESEARCH, 1991, 8 (05) :584-587
[7]   ONE-MONTH RELEASE INJECTABLE MICROSPHERES OF LEUPROLIDE ACETATE INHIBIT STEROIDOGENESIS AND GENITAL ORGAN GROWTH IN RATS [J].
OKADA, H ;
HEYA, T ;
IGARI, Y ;
OGAWA, Y ;
TOGUCHI, H ;
SHIMAMOTO, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 54 (03) :231-239
[8]  
OKADA H, 1992, P INT S CONTROL REL, V19, P52
[9]  
Okada H., 1987, U.S. Patent, Patent No. [4,652,441, 4652441]
[10]   LONG-ACTING DELIVERY SYSTEMS FOR PEPTIDES - INHIBITION OF RAT PROSTATE TUMORS BY CONTROLLED RELEASE OF [D-TRP6]LUTEINIZING HORMONE-RELEASING HORMONE FROM INJECTABLE MICROCAPSULES [J].
REDDING, TW ;
SCHALLY, AV ;
TICE, TR ;
MEYERS, WE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (18) :5845-5848